Meridian Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
Begins shipment of its ImmunoCard for detection of Clostridium difficile on Feb. 1 after receiving marketing clearance from FDA on Jan. 27. The test, which is the seventh ImmunoCard to be brought to market, lists for between $10 and $15 per test. Meridian licenses the ImmunoCard technology from Disease Detection International ("The Gray Sheet" May 6, 1991, In Brief).